Network Pharmacology Analysis of Tianwang Buxin Dan on Alzheimer’s Disease

作者
Wenjing Lü
出处
期刊:Journal of Biosciences and Medicines 卷期号:13 (06): 61-74
标识
DOI:10.4236/jbm.2025.136007
摘要

Background: This study explores the mechanism of action of Tianwang Buxin Dan in the treatment of Alzheimer’s disease (AD) by using the method of network pharmacology. Methods: Using traditional Chinese medicine system pharmacology database and analysis platform (TCMSP), search and screen the active ingredients of Tianwang Buxin Dan formula drugs; Search and screen the potential targets of compounds through Pubchem and Swiss Target Prediction databases; Retrieve the disease genes of Alzheimer’ disease from the DisGeNet database; Obtain the intersection genes of disease genes and active ingredient targets through Venny2.0 software; Then, the STRING database and Cytoscape software were used to construct and analyze the PPI network diagram and the network diagram of prescription drug active ingredient AD target for AD targets; Perform Gene Ontology (GO) enrichment analysis and KEGG pathway enrichment analysis separately by using the DAVID system. Results: There are a total of 458 intersecting genes between Tianwang Buxin Dan and AD. The top 10 core targets selected from Tianwang Buxin Dan are AKT1, IL6, TP53, IL1B, EGFR, ESR1, APP, and STAT3. The active ingredients can regulate KEGG Protein phosphorylation. The positive regulation of MAPK cascade, protein autophosphorylation, positive regulation of ERK1 and ERK2 cascade, peptidyl-tyrosine phosphorylation, signal transduction, and positive regulation of cell proliferation, can respond to xenobiotic stimulus and hypoxia by acting on the aforementioned AD targets, affect biological processes such as protein hydrolysis, protein phosphorylation, estrogen response, and inhibit the production of Aβ, reduce neuronal inflammation and apoptosis, weaken the cholinesterase activity, and ultimately achieve the goal of treating AD. Conclusions: By using network pharmacology methods to study the active ingredients and mechanism of action of Tianwang Buxin Dan in the treatment of AD, it was revealed that Tianwang Buxin Dan has the advantages of multiple components, targets, and pathways in the treatment of AD, providing new ideas for the later experiments of Tianwang Buxin Dan.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
zkx发布了新的文献求助10
1秒前
3秒前
3秒前
初(*^▽^*)心的应助被PDIF-CN2采纳,获得10
4秒前
汤汤完成签到 ,获得积分10
4秒前
melody发布了新的文献求助20
4秒前
孙强完成签到,获得积分20
4秒前
4秒前
Youdge的应助被LL采纳,获得20
4秒前
fengjingjing完成签到,获得积分10
5秒前
5秒前
芒果完成签到,获得积分10
5秒前
丘比特的应助被追寻的火车采纳,获得10
5秒前
执着白筠完成签到,获得积分10
5秒前
6秒前
7秒前
www发布了新的文献求助10
8秒前
blue发布了新的文献求助10
8秒前
yoooo发布了新的文献求助10
8秒前
白色茉莉花完成签到,获得积分10
9秒前
9秒前
9秒前
lkx发布了新的文献求助10
10秒前
11秒前
大树同志关注了科研通微信公众号
11秒前
wu完成签到,获得积分10
12秒前
12秒前
13秒前
mingyue完成签到,获得积分10
13秒前
Nole的应助被苏白浔采纳,获得30
13秒前
Nole的应助被苏白浔采纳,获得30
13秒前
烟花的应助被霸气皓轩采纳,获得10
13秒前
Nole的应助被苏白浔采纳,获得30
13秒前
My_magnum_opus的应助被苏白浔采纳,获得30
13秒前
星星完成签到,获得积分20
13秒前
传奇3的应助被典雅青槐采纳,获得10
15秒前
科研通AI6.4的应助被jingziye2004采纳,获得10
15秒前
和树完成签到,获得积分10
16秒前
Lucas的应助被任性的翼采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Erzählte Gnade 500
Butadiene hydroxytelechelic oligomers PBHT 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8082364
求助须知:如何正确求助?哪些是违规求助? 9497752
关于积分的说明 21403042
捐赠科研通 7650490
什么是DOI,文献DOI怎么找? 3401795
关于科研通互助平台的介绍 2530958
邀请新用户注册赠送积分活动 2440494